Differential beta-adrenoblocker therapy in chronic heart failure
Optimal pharmacotherapy of chronic heart failure (CHF) is essential for clinical outcome improvement. Recently, beta-adrenoblockers (BAB) have been regarded as first-line medications in CHD management. At the same time, their significant heterogeneity points to the need of differential administratio...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1604 |